In humans, the study of CNV associations with complex phenotypes is in high demand with a rich diversity of cost-effective methods [ 1, 2]; challenges in experimental design lie in the limited availability of relevant tissue samples.
On the other side, the diversity of the cost estimated depending on the country might only show that the method is not as useful as it has been considered until now.
This study uses data collected from multiple sites to examine the implications of product diversity for costing system design choices.
Even though literature search and assessment of the costing methodology followed a systematic approach, this is not a classical systematic review according to PRISMA-guidelines as the focus was rather on highlighting the diversity in cost assessment of existing economic evaluations rather than the assessment of their quality, which has been analysed elsewhere [10].
This suggests that sampling for genotyping/sequencing projects can be improved (in terms of diversity of sampling and cost) by taking into account independent knowledge of the demographic history of the populations being sampled.
The economic analyses were classified by their health outcome measures, with 18 studies assessed as being cost-consequences, reflecting the diversity of measures described above, 13 cost-minimisation, two cost-effectiveness, two cost-benefit and one cost-utility study.
The first important finding of this study is that there is a significant diversity in the cost of disability across European countries.
One important finding of this study is that there is a significant diversity in the cost of disability across European countries, with Scandinavian countries at the top of the ranking and Eastern European states at the bottom.
Natural compounds present characteristics such as high chemical diversity, lower cost of production and milder or non-existent side effects than conventional treatment (Kitazato et al., 2007).
They present characteristics such as high chemical diversity, lower cost of production and milder or inexistent side effects compared with conventional treatment.
The repetition code can achieve the maximum Doppler diversity at the cost of a lower spectral efficiency, and the DDM scheme can achieve the energy and spectral efficient Doppler diversity transmissions.
